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E-selectin is a cell-adhesionmolecule of the vascular endothelium that promotes essential leukocyte rolling in the early inflammatory
responsebybinding toglycoproteins containing the tetrasaccharide sialyl Lewisx (sLex). Efficient leukocyte recruitment under vascular
flow conditions depends on an increased lifetime of E-selectin/ligand complexes under tensile force in a so-called catch-bond binding
mode. Co-crystal structures of a representative fragment of the extracellular E-selectin regionwith sLex and a glycomimetic antagonist
thereof reveal an extended E-selectin conformation, which is identified as a high-affinity binding state of E-selectin by molecular
dynamics simulations. Small-angle X-ray scattering experiments demonstrate a direct link between ligand binding and E-selectin
conformational transition under static conditions in solution. This permits tracing a series of concerted structural changes connecting
ligand binding to conformational stretching as the structural basis of E-selectin catch-bond-mediated leukocyte recruitment. The
detailed molecular view of the binding site paves the way for the design of a new generation of selectin antagonists. This is of
special interest, since their therapeutic potential was recently demonstratedwith the pan-selectin antagonists GMI-1070 (Rivipansel).
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Introduction
E-, P-, and L-selectin are a family of Ca2+-dependent C-type
lectins mediating cell-cell adhesion in the vascular system with a
pivotal role in inflammation (Lasky, 1995). They are expressed on
the vascular endothelium (E-, P-selectin), platelets (P-selectin),
or leukocytes (L-selectin) and bind to cell-surface glycoproteins,
e.g. P-selectin glycoprotein ligand-1 (PSGL-1) or E-selectin
ligand-1 (ESL-1) presenting the minimal tetrasaccharide binding
motif sialyl Lewisx (sLex, Figure 1A) (Phillips et al., 1990; Walz
et al., 1990; Polley et al., 1991). Selectins exhibit catch-bond be-
havior: The lifetime of complexes of selectins with their ligands
increases under tensile force conditions (Thomas et al., 2008) as
demonstrated first by atomic force microscopy and flow chamber
assays for P-selectin (Marshall et al., 2003; Waldron and
Springer, 2009), later also for L-selectin (Finger et al., 1996;
Ramachandran et al., 1999; Sarangapani et al., 2004; Lou et al.,
2006; Zhu et al., 2008), and most recently for E-selectin (Snook
and Guilford, 2010; Wayman et al., 2010). For E- and P-selectin,
the catch-bond binding mode is required under flow conditions
for efficient leukocyte tethering and rolling along the vascular
endothelium, a prerequisite for subsequent firm adhesion and
transmigration to sites of inflammation (Kansas, 1996). Due to
their essential role in leukocyte recruitment, selectins are an
attractive target for therapeutic intervention against diseases in-
volving excessive inflammatory response as found in numerous
cardiovascular and autoimmune diseases (Ley, 2003). A first dem-
onstration of the therapeutic potential of selectin inhibition was
very recently achieved by successful completion of phase-II clinical
trials of the pan-selectin antagonists GMI-1070 (Rivipansel) for the
treatment of the vaso-occlusive crisis in sickle-cell disease
(Clinicaltrials.gov, 2014a, b). The success of GMI-1070 now paves
the way for the development of selectin type-specific antagonists
for further indications.
The selectins shareaconserveddomain architecture (Figure1B) with
an N-terminal lectin (Lec) domain, which contains the carbohy-
drate-binding site, an epidermal growth factor (EGF)-like domain,
variable numbers of short consensus repeat (SCR) domains, a
single-span transmembrane region, and a C-terminal cytoplasmic
domain. Isolated Lec-EGF didomain fragments are sufficient for
ligand binding (Erbe et al.,1992); however, as demonstrated in cell-
based assays, their affinity improves with an increasing number of
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attached SCR domains (Li et al., 1994). Several models have been
established to link the catch-bond phenomenon to the structure of
selectins and their ligands. In the sliding-rebinding model, the
alignment of the binding interface to the tensile force allows the
ligand to slide along the protein surface and continuously form
new interactions (Lou et al., 2006; Lou and Zhu, 2007). Other
models build upon an allosteric relationship between force-
induced domain separation and conformational changes in the
binding site (Thomas et al., 2006; Yakovenko et al., 2008;
Springer, 2009). In the one-state-two-pathway model, a single
low-energy state exists under no-force conditions with a high rate
of unbinding (Pereverzev et al., 2005). When force is applied, the
protein switches into a conformation with a decreased rate of
unbinding, thus allowing for longer lifetimes of the interactions.
In the two-state-two-pathway model, high- and low-affinity confor-
mations are in equilibrium under no-force conditions and the ligand
can dissociate from either conformational state, albeit at different
rates (Evans et al., 2004; Beste and Hammer, 2008). Under force
conditions, the high-affinity state is preferred, leading to decreased
unbinding up to a certain force threshold.
Currently, a single conformational state of the Lec-EGF didomain
has been visualized for apo-P- and E-selectin as well as for sLex-
bound P- and E-selectin in crystallographic soaking experiments
(Graves et al., 1994; Somers et al., 2000). However, the crystal struc-
ture of the P-selectin Lec-EGF didomain co-crystallized with a large
tyrosine-sulfated glycopeptide fragment of its physiological glycopro-
tein ligand PSGL-1, yielded a second, more extended conformation,
suggesting a mechanism of conformational coupling specific for the
binding of P-selectin to its multivalent peptide ligand (Somers et al.,
2000). It remains unclear how catch-bond behavior is mediated in
E- and L-selectin and whether small-molecule ligands are capable of
mediating conformational transitions. To analyze the crosstalk
between conformational changes and binding of the natural tetra-
saccharide epitope sLex and the glycomimetic 1 (Figure 1A) to
E-selectin, we used a representative four-domain fragment
(E-selectin*) of the extracellular region of E-selectin comprising
the Lec and EGF-like domains as well as two SCR domains. While
sLex has a weak affinity for E-selectin (KD 878 mM), glycomimetic
1 exhibits an enhanced affinity in the low micromolar range (KD
19 mM) (Binder et al., 2012). Here, sialic acid and N-acetyl-D-
glucosamine (GlcNAc) are replaced by (S)-cyclohexyl lactic acid
and (1R,2R,3S)-3-methylcyclohexane-1,2-diol, respectively. Com-
bining structural information from co-crystallizing E-selectin* with
sLex or glycomimetic 1 with molecular dynamics simulations and
solution small-angle X-ray scattering (SAXS), we reveal a novel
high-affinity binding state relevant for catch-bond interactions in
E-selectin and provide the basis for future rational drug design of
potent E-selectin antagonists.
Results
Toanalyzethe implications of ligand binding toE-selectin, wedeter-
mined the crystal structures of a representative fragment of the
E-selectin extracellular region (E-selectin*) with either sLex or the gly-
comimetic 1. Secreted E-selectin* was expressed in CHO cells and
purified by affinity chromatography with antibody 7A9, which
blocks E-selectin functionality (Rodriguez-Romero et al., 1998). The
purified protein after deglycosylation (Supplementary Figure S1) con-
tains single GlcNAc residues attached to each of the seven predicted
N-glycosylation sites and is functional in ligand binding assays
(Supplementary Figures S2 and S3). E-selectin* co-crystals with
Figure 1 E-selectin ligands and selectin domain arrangement. (A) Chemical structures of sialyl Lewisx (sLex) and glycomimetic 1 (Schwizer et al.,
2012). (B) Comparison of human L-, E-, and P-selectin. The representative E-selectin fragment used in this publication (E-selectin*) is boxed and
domains are colored red, orange (SCR domains), magenta (EGF), and green (lectin) as in following figures.
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sLex or glycomimetic 1were obtained in crystallization conditions
based on polyethylene glycol 8000 in the presence of 0.2 M CaCl2
and diffracted to 2.40 A˚ and 1.93 A˚, respectively. Structure deter-
mination was carried out by molecular replacement, final struc-
tures were refined to Rwork/Rfree 0.217/0.253 and 0.183/0.232
for sLex and glycomimetic 1 co-crystals, respectively, with two vir-
tually identical molecules per asymmetric unit (Supplementary
Table S1). Omit electron density maps for the ligand-binding
site and hinge regions are shown in Supplementary Figure S4.
E-selectin ligand complexes adopt an extended linear
conformation
Both ligand complexes of E-selectin* adopt an extended shape
with a total length of 135 A˚ (Figure 2A). The binding modes of the
physiological sLex ligand and glycomimetic 1 are almost identical
(Figure 3A); both ligands bind into the same deep binding pocket
covered by the loop 83–88, and their L-fucose moieties coordinate
the central Ca2+ ion of the Lec domain. However, compared with
previously published structures of E-selectin Lec-EGF didomain
fragments (Graves et al., 1994; Somers et al., 2000), either
without ligand or with sLex soaked into preformed protein crystals,
considerable rearrangements in the ligand-binding site and a tran-
sition from a bent to an extended shape of the Lec-EGF didomain are
observed (Figure 3B). The SCR domains, which have not been pre-
viously visualized in the context of selectin Lec-EGF didomains,
align in both ligand complexes in a linear fashion with the EGF
domain (Figure 2B). Since E-selectin*/1 crystals diffract to higher
resolution, the discussion focuses on this complex.
Figure 2 E-selectin short consensus repeat domains are linear rigidified domains. (A) Structure of E-selectin with the N-terminal Lec, the EGF-like,
and the first two SCR domains. The glycomimetic1 coordinates the Ca2+ ion (magenta) in the carbohydrate recognition site. SevenN-linked GlcNAc
moieties are located at interdomain interfaces. (B) The SCR domains are aligned, with a908 rotation of SCR2 relative to SCR1. Three disulfide bonds
stabilize each SCR domain. Conserved tryptophans (Trp209/271) are wedged between the upper and central disulfide bond. SCR domain flexibility
is limited by hydrogen bonds between Gly147 and Val157 or Gly192 and Val219.
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Rigidified short consensus repeats at the basis of the selectin
extracellular domain
In selectins, between two and nine SCR domains provide the
coupling of the Lec-EGF didomain to the cell surface. E-selectin
comprises six SCR domains, two of which are included in
E-selectin*. The sequence conservation of selectin SCR domains
is low (Supplementary Figure S5); however, they all consist of a
60 amino acid compact b-sheet fold (Figure 2B) and contain six
conserved cysteines, two more than most other SCR domains
(Supplementary Table S5 and references therein). These cysteines
form three intradomain disulfide bonds, two common ones at each
end of the domain, and an additional disulfide bond in the center.
A conserved tryptophan (SCR1:Trp209, SCR2:Trp271) is interlocked
between the N-terminal and the central disulfide bond (Figure 2B)
resulting in the formation of a tightly packed rigid core in selectin
SCR domains. The two successive SCR domains are rotated by
908 relative to each other. This orientation is stabilized by an inter-
action of the loop Gly192 backbone oxygen with the backbone NH
of the linker region Val219. A similar stabilizing interaction is
observed at the EGF/SCR1 interface between Gly147 and Val157.
The linker between the linearly arranged E-selectin SCR1-2
domains is composed of only four residues (Asn217, Val218,
Val219, and Glu220), while linker lengths of five to eight residues
have been observed in non-linearly arranged SCR domains (Prota
et al., 2002). In contrast to SCR domain linkers in other proteins,
the pattern of hydrophilic-hydrophobic-hydrophobic-hydrophilic
amino acids is well conserved in all selectin SCR linkers, except
between SCR7 and 8 in P-selectin (Supplementary Figure S5), indi-
cating a critical role of linker composition and stabilizing interdo-
main interactions for selectin function.
Figure 3 E-selectin adopts an extended overall conformation upon ligand binding. (A) Superposition of sLex soaked into preformed crystals
(Somers et al., 2000) (gray, upper panel) and the co-crystallized glycomimetic 1 (green, lower panel) onto the co-crystallized sLex (purple). (B)
Apo-E-selectin (blue, PDB code 1ESL) (Graves et al., 1994) and E-selectin soaked with sLex (gray, PDB code 1G1T) (Somers et al., 2000) adopt
a bent conformation. The extended state observed in co-crystals with sLex (magenta) or glycomimetic 1 (green) is characterized by a separation
of the Lec and EGF-like domains. Root-mean-square deviations (rmsd) were calculated for Lec and EGF-like domains only. The ligand-binding Ca2+
ion is depicted as a magenta sphere, Ca atoms of Trp1 (pivot) and Cys144 (EGF-like domain) as red spheres.
E-selectin extended conformation | 65
Downloaded from https://academic.oup.com/jmcb/article-abstract/8/1/62/2459544
by WWZ Bibliothek (Oeffentliche Bibliothek der UniversitÃ¤t Basel) user
on 08 November 2017
The first E-selectin SCR domain possesses three N-linked glyco-
sylation sites (Asn158, Asn178, Asn182), while the second SCR2
has a single site (Asn244). The observed glycosylation sites are
located at the interface of the EGF-like/SCR1 and SCR1/SCR2
domains. While SCR4 and SCR5 have no predicted glycosylation
sites, SCR3 and SCR6 each carry two at position 291, 311 (SCR3)
and482,506 (SCR6). Based on the SCR1/2 structure, glycosylation
at residue 291 is located at the interface to SCR2, and both sites in
SCR6 are in close proximity to the membrane surface. This arrange-
ment indicates that glycosylation may contribute to protection of
exposed SCR domain linking regions against proteolytic cleavage,
as generally observed for other glycosylated proteins (Imperiali
and O’Connor, 1999; Kundra and Kornfeld, 1999; Crothers et al.,
2004). Together with the conserved tryptophans, the additional di-
sulfide bond and the conserved linker region, glycosylation thus
contributes to the formation of a reinforced SCR stalk for mechan-
osensing by the Lec-EGF didomain.
Ligand binding induces the extended high-affinity conformation
of E-selectin
The relative orientation of the Lec and EGF domains observed
here in both ligand complexes is considerably different from the
bent conformation observed previously in crystals of a E-selectin
Lec-EGF didomain fragment without ligand or soaked with sLex
(Graves et al.,1994; Somers et al.,2000). In the bent conformation,
the angle between the Lec and EGF domains is 1208, while it is
1418 and 1518 in the current co-crystal structures (Figure 3B and
Supplementary Video S1). This bent-to-extended movement
occurs by a rotation around a pivot at the Lec-EGF interface and
results in a separation of the two domains.
To confirm that ligand binding directly promotes the extended
conformation of E-selectin in solution, we employed SAXS as a
label-free and sensitive technique for detecting conformational
changes. Calculated SAXS curves reveal a small but characteristic
difference between models of the apo-E-selectin* bent and the
ligand-bound extended conformation at q ¼ 0.3–0.4 A˚21 (black
and red lines in Figure 4A and B). Indeed, the experimental scatter-
ing curve for E-selectin* in absence of ligand is in good agreement
only with the calculated curve for the apo-E-selectin* model,
whereas the scattering curve in the presence of glycomimetic 1
exhibits the expected shift at q ¼ 0.3–0.4 A˚21 and correlates
well with the E-selectin*/1 model (Figure 4B). These results dem-
onstrate that the solution conformation closely resembles the con-
formation in the crystal structures. Ligand binding therefore indeed
shifts the conformational equilibrium of E-selectin from the bent to
the extended state, while the linear arrangement of SCR domains is
maintained irrespective of the presence or absence of the ligand.
We employed molecular dynamics simulations to calculate rela-
tive binding free energies for the bent and extended conformation
of E-selectinand, due to limitations of the method (seeSupplementary
material for details), scaled the absolute values according to our
previously reported data from isothermal titration calorimetry
(Binder et al., 2012). The obtained difference of 0.82 kcal/mol for
the binding of the natural sLex ligand demonstrates that additional
interactions of protein and ligand in the extended conformation
result in higher interaction energies in comparison to the shallow
binding site in the bent state (Supplementary Table S4). This
change in binding free energy translates into a four-fold increase
in the dissociation constant (KD) and supports the notion that the
extended conformation represents a true high-affinity binding
state of E-selectin.
The conformational coupling mechanism of E-selectin
Alterations in the Lec domain connect ligand binding to conform-
ational change. Three regions located in the Lec domain are
affected by conformational changes upon ligand binding: The
Figure 4 In solution SAXS analysis reveals the conformational differ-
ences between apo-E-selectin and the E-selectin/1 complex. (A and
B) Calculated (black or red lines) and experimental (circles) scattering
curves of E-selectin in absence (gray circles) or presence (green circles)
of the ligand. Error bars correspond to the standard error of the means
of eleven measurement points. (A) In absence of glycomimetic 1,
E-selectin adopts the bent conformation. (B) In presence of the
ligand, the experimental scattering curve shows a significant shift at
q ¼ 0.3–0.4 A˚21 corresponding to a transition toward the extended
conformation.
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binding site loop 81–89 changes its conformation (Figure 5A), and
a bridging region formed by two loops (residues52–75) transduces
this motion (Figure 5B) to the pivot region consisting of the pivot
residue Trp1 (Figure 5C) and surrounding residues in the Lec
(residues 22–23 and 30–31, Figure 5C and D) and in the EGF-like
domain (Asn138). These variable regions are mounted onto a
rigid scaffold of the Lec domain, stabilized by two disulfide bonds
(Cys19–Cys117 and Cys90–Cys109). The alterations extend over
Figure 5 The bent and extended conformation of E-selectin exhibit differences in the ligand-binding site reaching to the Lec-EGF domain interface.
(A) The binding site is constricted by rearrangements of loop 81–89. Glu88 replaces Asn83 as Ca2+ coordinating residue and forms an additional
interaction with the 2-hydroxyl group of L-Fuc. (B) The bridging region 52–70 undergoes a rigid body motion breaking the interactions of Arg54/
Lys55 with Asp89 of the binding site. At the pivot interface, a water-mediated hydrogen bond network involving Gly52, Val63, and Leu26 is per-
turbed. (C) Within the pivot region, Ile29 and Gln30 flip orientation, which disrupts interdomain interactions to Glu135 and favors a dislocation of
Trp1, leading to the hinge-bending motion between the Lec and EGF domains. The Tyr37–Asn138 interdomain interaction is broken. (D) Another
shift in the pivot region originates at the GlcNAc residue linked to Asn4. The interaction of Arg22with the carbohydrate further disrupts interdomain
interactions and releases the Tyr118 side chain toward the pivot residue Trp1.
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35 A˚ from the carbohydrate-binding site to the interface with the
EGF-like domain.
The ligand-binding site. The most extensive conformational
changes are observed within the binding site loop 81–89
(Figure 5A), where the Ca atom of residue Gln85 moves by 10 A˚
(see Supplementary Video S2). This leads to a constriction around
the central Ca2+ ion and the L-fucose (L-Fuc) moiety of the ligand,
which coordinates the Ca2+ ion with its3- and4-hydroxyl groups. In
the bent conformation Asn83 coordinates the Ca2+ ion, while in the
extended conformation Glu88 swings inwards to coordinate the
Ca2+ ion and displaces Asn83 toward the solvent. This swapping
is supported by an additional interaction between Glu88 and the
2-hydroxyl group of L-Fuc. Gln85, which is solvent-exposed in the
bent conformation, also shifts toward the ligand into hydrogen
bonding distance to the 2-hydroxyl group. Thus, as a consequence
of the conformational adaptation, the2-hydroxyl group of L-Fuc dir-
ectly interacts with the protein in the extended conformation, while
it is only involved in water-mediated interactions to Glu107 and
Asn83 in the bent conformation. These findings explain the import-
ance of the L-Fuc 2-hydroxyl group for ligand affinity (Brandley
et al., 1993; Ramphal et al., 1994), which was not rationalized by
earlier structural data (Somers et al., 2000). Finally, also the loop
around Pro46 shifts from an original distance of 6.8 A˚ to the
6-hydroxyl group of the D-galactose (D-Gal) moiety in the bent con-
formation toward 4.5 A˚ in the extended conformation, where the
backbone oxygen of Pro46 mediates a water-bridged interaction
to the 6-hydroxyl group of D-Gal.
The bridging region. The constriction around the L-Fuc binding
site leads to the disruption of interactions at the interface of the
binding site and the bridging loops 52–75 (Figure 5B) between
the Asp89and Arg54side chains and Lys55backbone, respectively.
The bridging region itself shifts in a rigid body motion from the bent
to the extended conformation. This rigidity is maintained by back-
bone interactions between Arg54 and Trp60/Val61, Gly52 and
Val63 as well as Trp60 and Leu69. The rigid body motion serves
as an allosteric bridge for transmitting the conformational alter-
ation from the binding site to the pivot region.
The pivot region. The E-selectin bent conformation is stabilized
by an extensive hydrogen bond network between the Lec and
EGF-like domains with main contributions from Trp1, Thr24,
Gln30, Tyr37, Ala120, Glu135, and Asn138 (Figure 5C and D). The
Trp1hinge residue is the only residue of the Lec domain that coher-
ently moves with the EGF-like domain to the extended conform-
ation. This motion is accompanied by (i) a flip of residues Ile29/
Gln30 (Figure 5C), (ii) a flip of residues Tyr23/Thr24 accompanied
by an altered side chain conformation of Arg22 (Figure 5D), and
(iii) a disruption of the interdomain interaction between Tyr37/
Asn138 (Figure 5C). A flip of the residues Ile29 and Gln30,
located in a solvent exposed loop with increased flexibility
between helix 1 and 2 of the Lec domain, facilitates the movement
of Trp1 (Figure 5C). In the bent conformation, Ile29 is enclosed
in a hydrophobic pocket, while Gln30 is involved in intra- and
interdomain interactions to Glu34 and Glu135. When the extended
conformation is adopted, the steric hindrance of Trp1 on Ile29 and
Gln30 is released and the flipped conformation of Gln30 is stabi-
lized by new interactions with the backbone oxygen of Gly102
and the side chain of Trp104. These rearrangements in the pivot
region disrupt a contact to the bridging region mediated by a
water molecule bridging the backbone of Leu26 to Gly52/Gly64
(Figure 5B). As a consequence, the pivot and bridging regions are
further separated and additional water molecules enter into the
crevice between the domains. Tyr23 and Thr24 are restrained in
the bent conformation by the side chain of Arg22. While Arg22
stacks with Tyr18 in the bent conformation, its side chain
is re-oriented in the extended conformation and interacts with
the GlcNAc attached to Asn4. The movement of Arg22 provides
space for a flip of residues Tyr23 and Thr24 of the pivot region
(Figure5D). Tyr23 relaxes from an unfavorable into a favorable pos-
ition in the Ramachandran plot. The new conformation is stabilized
by an interaction of the Thr24 side chain with the Cys19 backbone
oxygen. The flip of Tyr23/Thr24 further disrupts interactions
between the Lec and EGF-like domains, namely between Thr24
backbone and Tyr118 backbone and Thr24 side chain with
Ala120. The side chain of Tyr118 enters into a cleft that is opened
by the movement of Trp1. A hydrogen bond between Tyr37 and
Asn138 contributes to the interface between the Lec and EGF-like
domains in the bent conformation of E- and L-selectin (PDB code
3CFW). In the E-selectin*/1 structure, the Asn138 residue is
pushed toward the Lec domain, thus disrupting the interdomain
hydrogen bond to Tyr37 (Figure 5C). This conformational change
is additionally accompanied by a backbone flip between Ile137
and Asn138.
Comparative analysis of mechanocoupling in E- and P-selectin
A transition from bent to extended conformation in selectins
has previously been observed only for the Lec-EGF didomain of
P-selectin co-crystallized with a multivalent PSGL-1 peptide ligand
(Somers et al., 2000). This peptide comprised the 19 N-terminal
amino acids of mature PSGL-1, including an sLex-modified glycan
attached to Thr16 and three sulfated tyrosine residues, which are
directly involved in protein ligand interactions (Sako et al., 1995;
Wilkins et al., 1995; Somers et al., 2000). Based on the P-selectin/
PSGL-1 crystal structure, a P-selectin-specific mechanism for con-
formational coupling was proposed (Springer, 2009). Despite a
sequence identity in the Lec and EGF-like domains of 62% between
E- and P-selectin (Supplementary Figure S6), two key differences
between E- and P-selectin supported the P-selectin-specificity of
the proposed mechanism: First, E-selectin does not interact with
sulfated tyrosines, while those mediate key protein–ligand inter-
action in the P-selectin/PSGL-1 complex (Li et al., 1996; Rodgers
et al., 2000). Second, differences in the Lec-EGF domain interface
suggested a stabilization of the bent conformation in E-selectin
by an additional hydrogen bond (Graves et al., 1994; Somers
et al., 2000). The current data demonstrate that E- and P-selectin
undergo a similar overall conformational change, but with consid-
erable differences in the mechanism of conformational coupling.
(i) The E-selectin Lec-EGF domain interface is locked by a hydrogen
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bond between Asn138 and Tyr37. This interaction is absent in
P-selectin, which carries a glycine at position 138. The functional
relevance of this interdomain interaction was demonstrated on
L-selectin, where an Asn138Gly mutant improved ligand binding
under hydrodynamic force (Lou et al., 2006; Phan et al., 2006). It
has been hypothesized, that Asn138 would be forced into an un-
favorable backbone conformation upon disruption of the Tyr37-
Asn138 hydrogen bond, which would finally prevent the transition
into the extended state (Springer, 2009). The backbone flip
between residues 137 and 138 observed here, now demonstrates
how such non-favored conformation is avoided. (ii) While the
Trp1 residue has also been identified as the pivot for P-selectin,
the flip of the Ile29 and Gln30 side chains was not observed. (iii)
Residue Tyr23 in the direct vicinity of the pivot residue Trp1 is un-
altered in the bent and extended conformation of P-selectin,
while it relaxes from an unfavorable into a favorable backbone con-
formation for E-selectin.
Discussion
The catch-bond behavior of selectins is crucial for their ability to
mediate leukocyte rolling and is achieved by a transition between a
bent and an extended conformational state (Marshall et al., 2003;
Waldron and Springer, 2009; Snook and Guilford, 2010; Wayman
et al., 2010). This has been elegantly demonstrated by forcing
P-selectin into an extended conformation by modifications at
the Lec-EGF interface: A P-selectin variant locked in an extended
conformation displays enhanced ligand binding under static condi-
tions, but its ability to mediate leukocyte rolling under flow condi-
tions was impaired (Phan et al., 2006; Waldron and Springer,
2009). However, an extended conformation has so far only been
observed for P-selectin in complex with a glycopeptide ligand
that interacts with its carbohydrate epitope as well as three sul-
fated tyrosines. Here, we reveal an extended state of E-selectin in
complex with its minimal binding motif sLex. Based on an analysis
of protein–ligand interactions and quantitative analysis of molecu-
lar dynamics simulations, this extended conformation represents a
true high-affinity ligand-binding state of E-selectin. With SAXS
measurements we demonstrate for the first time for any selectin,
that small-molecule ligand-binding induces a conformational tran-
sition from the bent low affinity to the extended high-affinity state
in solution. Therefore, glycoprotein ligands such as PSGL-1 or
ESL-1 are not strictly required for efficiently promoting conform-
ational changes in selectins. Even a small molecular ligand such
as sLex in the absence of flow conditions is sufficient to initiate a
structural transition to an extended conformation.
To analyze the functional mechanisms underlying catch-bond
behavior, detailed structural knowledge of all relevant states of
E-selectin is required (Figure 6). Apo-E-selectin adopts a bent con-
formation of the Lec-EGF didomain as demonstrated by crystallo-
graphic analysis (Graves et al., 1994) and SAXS data. The bent
conformation is capable of recognizing and weakly binding sLex,
as demonstrated in a crystallographic ligand soaking experiment,
where crystal packing restraints prevented the transition to the
extended conformation (Somers et al., 2000). However, in solution
ligand binding results in a conformational transition into the extended
high-affinity binding state revealed here by co-crystallization and
SAXS. The conformational change from a bent to an extended con-
formation allows E-selectin to support fast binding of rapidly
flowing leukocytes to the vascular endothelium at the leading
edge of the cell while controlling the rate of unbinding at the trailing
edge, thus providing mechanical stability to the rolling of leuko-
cytes along the vasculature. Under in vivo flow conditions, the
extended conformation is favored by tensile force pulling along
the E-selectin–ligand axis reinforcing the extended conformation
and thus increasing lifetime of the interaction. The rigidity of the lin-
early arranged SCR domains is promoted by conserved interdomain
contacts and three intradomain disulfide bonds and provides a
basis for mechanosensing by the Lec-EGF didomain of E-selectin.
Our findings provide direct evidence for the two-state-two-pathway
model of conformational changes underlying catch-bond proper-
ties in E-selectin (Figure 6). The bent conformation is prevailing
in solution and recognizes ligands in a low-affinity encounter
complex. The encounter complex undergoes a conformational
change to a high-affinity extended state already under no-force
conditions, but tensile force acting along the Lec-EGF–ligand-
binding site axis further increases its lifetime. Such a two-state-
two-pathway model has been previously proposed for the P-selectin/
PSGL-1 complex (Evans et al., 2004), for the bacterial adhesin
FimH in complex with mannose (Thomas et al., 2006), and most re-
cently for the cadherin-catenin complex binding to actin filaments
(Buckley et al., 2014). So far, P-selectin was the only system for
which two distinct ligand-bound states have been structurally char-
acterized, but with very different low- (sLex) and high-molecular
weight (PSGL-1) ligands (Somers et al., 2000). Our current data to-
gether with the previous low-affinity E-selectin/sLex structure
(Somers et al., 2000) provide for the first time a comprehensive
view on the full set of apo- as well as low- and high-affinity struc-
tures underlying the catch-bond behavior with one and the same
natural ligand.
The ligand-binding site of E-selectin undergoes dramatic con-
formational changes between the low-affinity and the high-
affinity state (Supplementary Video S1). The shallow binding
surface is transformed into a pronounced binding pocket with
multiple additional protein– ligand interactions, while the con-
formation of the ligand remains unchanged. Co-crystallization
with the glycomimetic 1 demonstrates the relevance of the high-
affinity conformation for the design of drug candidates targeting
E-selectin. The detailed knowledge into ligand recognition of
E- and P-selectin opens the way toward the rational design of
novel E-selectin-specific antagonists. Based on the success
of the pan-selectin antagonist Rivipansel, E-selectin-specific
antagonists are promising drug candidates that may further
target specific indications related to excessive inflammatory
responses in human disease. In summary, the current results con-
tribute to a comprehensive understanding of the mechanism of
mechanosensing and catch-bond behavior in the selectin family
and they reveal the pathway of ligand-induced conformational
changes in E-selectin with critical relevance for ongoing targeted
drug discovery.
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Materials and methods
Ligand synthesis
The glycomimetic 1 {(1R,2R,3S)-2-[(a-L-fucopyranosyl)oxy]-3-
methyl-cyclohex-1-yl} 3-O-[sodium (1S)-1-carboxy-2-cyclohexyl-
ethyl] -b-D-galactopyranosidewassynthesizedasreportedpreviously
(Schwizer et al., 2012). The tetrasaccharide trimethylsilylethyl
sialyl Lewisx (sLex-OTMSE) was synthesized as described in
Supplementary material.
Protein expression and purification
The coding sequences of the human E-selectin Lec-EGF-SCR1+2
domains (E-selectin*) cDNA were cloned into the pcDNA3.1(+)
expression vector (Life Technologies Ltd) using standard proce-
dures. Stably transfected CHO-K1 cells (ATCC-No. CCL-61) were
generated using FuGENEw HD (Roche Applied Science) transfec-
tion, G418 treatment, and subsequent clone selection. Protein
expression was carried out in monolayer cultures in the presence
of kifunensine. Purification using the functional anti-E-selectin
antibody 7A9 coupled to sepharose was carried out as described
previously (Binder et al., 2012). Concentrated high-mannosylated
E-selectin was partially deglycosylated with endoglycosidase H
yielding protein with seven single GlcNAc moieties attached to
each N-linked glycosylation site. For details see Supplementary
material.
Co-crystallization and structure determination
Deglycosylated E-selectin* was co-crystallized with sLex-OTMSE
or glycomimetic 1 in a sitting drop setup in the presence of 0.2 M
CaCl2using polyethylene glycol8000as precipitant. Plate-like crys-
tals appeared within 1 day after seeding. The structures of
E-selectin*/1 and E-selectin*/sLex were determined by molecular
replacement and refined using BUSTER (Blanc et al., 2004). For
details on data collection and refinement see Supplementary ma-
terial (Supplementary Table S1).
Small-angle X-ray scattering
SAXS measurements were conducted at beamline x12sa-cSAXS
of the Swiss Light Source using partially deglycosylated E-selectin*
in presence or absence of 3 mM glycomimetic 1. Experimental data
were processed with PRIMUS (Konarev et al., 2003) and theoretical
Figure 6 The ligand-dependent equilibrium between bent and extended conformation of E-selectin. In absence of ligand, E-selectin primarily
adopts the bent conformation (A) and not an extended conformation (D). The bent conformation is capable of ligand binding (B), although with
low affinity. Upon ligand binding E-selectin favors the extended high-affinity state (C). Tensile force along the E-selectin–ligand axis exerted by
tethered leukocytes under flow conditions increases the lifetime of the high-affinity conformation.
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scattering curves were evaluated with CRYSOL (Svergun et al.,
1995). A model for the E-selectin* bent conformation was gener-
ated using the coordinates of the apo-form of the E-selectin
Lec-EGF didomain (Graves et al., 1994) combined with the coordi-
nates of the two SCR domains from E-selectin*/1. For details see
Supplementary material (Supplementary Table S2).
Molecular dynamics simulations
Molecular dynamics simulations were carried out using the OPLS
2005 force field at a constant temperature of 300 K. Energetic and
structural data were recorded in4.8ps intervals. From the collected
frames, every tenth (1000 frames in total) was used to calculate
the average DG applying the molecular mechanics generalized
Born surface area (MM-GBSA) method. The details are described
in Supplementary material (Supplementary Tables S3 and S4).
Supplementary material
Supplementary material is available at Journal of Molecular Cell
Biology online.
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